Literature DB >> 17827462

Chemoradiotherapy for locally advanced head and neck cancer.

Joseph K Salama1, Tanguy Y Seiwert, Everett E Vokes.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17827462     DOI： 10.1200/JCO.2007.12.2697

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  25 in total

Review 1.  Head and neck cancer: an evolving treatment paradigm.

Authors:  David M Cognetti; Randal S Weber; Stephen Y Lai
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck.

Authors:  Vittal V S Kurisetty; Joshua Heiber; Rae Myers; Guilherme S Pereira; Jarrard W Goodwin; Mark J Federspiel; Stephen J Russell; Kah Whye Peng; Glen Barber; Jaime R Merchan
Journal:  Head Neck       Date:  2014-02-01       Impact factor: 3.147

3.  Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer.

Authors:  A Argiris; M V Karamouzis; R Smith; A Kotsakis; M K Gibson; S Y Lai; S Kim; B F Branstetter; Y Shuai; M Romkes; L Wang; J R Grandis; R L Ferris; J T Johnson; D E Heron
Journal:  Ann Oncol       Date:  2011-03-01       Impact factor: 32.976

4.  Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.

Authors:  Aaron W Pederson; Joseph K Salama; Daniel J Haraf; Mary Ellen Witt; Kerstin M Stenson; Louis Portugal; Tanguy Seiwert; Victoria M Villaflor; Ezra E W Cohen; Everett E Vokes; Elizabeth A Blair
Journal:  Head Neck Oncol       Date:  2011-07-26

5.  Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.

Authors:  Anuradha Soundararajan; Gerald D Dodd; Ande Bao; William T Phillips; Linda M McManus; Thomas J Prihoda; Beth A Goins
Journal:  Radiology       Date:  2011-10-24       Impact factor: 11.105

6.  DNA microarray reveals ZNF195 and SBF1 are potential biomarkers for gemcitabine sensitivity in head and neck squamous cell carcinoma cell lines.

Authors:  Min-Hui Zhu; Shun-Long Ji; Cai-Yun Zhang; Long Cui; Lei Xiong; Hong-Liang Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

7.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck.

Authors:  Daniel A Hamstra; Kuei C Lee; Bradford A Moffat; Thomas L Chenevert; Alnawaz Rehemtulla; Brian D Ross
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

8.  Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer.

Authors:  Iris Gluck; Felix Y Feng; Teresa Lyden; Marc Haxer; Francis Worden; Douglas B Chepeha; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-23       Impact factor: 7.038

9.  Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience.

Authors:  Anne M Traynor; Gregory M Richards; Gregory K Hartig; Deepak Khuntia; James F Cleary; Peggy A Wiederholt; Søren M Bentzen; Paul M Harari
Journal:  Head Neck       Date:  2010-05       Impact factor: 3.147

10.  MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer.

Authors:  George Fountzilas; Anna Kalogera-Fountzila; Sophia Lambaki; Ralph M Wirtz; Angelos Nikolaou; Georgia Karayannopoulou; Mattheos Bobos; Vassiliki Kotoula; Samuel Murray; Alexandros Lambropoulos; Gerasimos Aravantinos; Konstantinos Markou; Eleni Athanassiou; Despina Misailidou; Konstantine T Kalogeras; Demosthenis Skarlos
Journal:  J Oncol       Date:  2009-12-29       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.